Antineoplastics/thalidomideTumour lysis syndrome: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1422卷 / 1期

关键词：

Dexamethasone; Doxorubicin; Uric Acid; Multiple Myeloma; Furosemide;

D O I：

10.2165/00128415-201214220-00031

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：10 / 10

相关论文

共 50 条

[1] ThalidomideTumour lysis syndrome: case report
Reactions Weekly, 2004, 1001 (1) : 14 - 14
[2] Bortezomib/dexamethasone/thalidomideTumour lysis syndrome: case report
Reactions Weekly, 2008, 1206 (1) : 8 - 8
[3] RituximabTumour lysis syndrome: 2 case reports
Reactions Weekly, 2000, 796 (1) : 9 - 9
[4] BortezomibTumour lysis syndrome: 3 case reports
Reactions Weekly, 2006, 1115 (1) : 8 - 8
[5] RituximabAcute tumour lysis syndrome in elderly patients: 2 case reports
Reactions Weekly, 2012, 1405 (1) : 32 - 32
[6] Doxorubicin/ethiodized oilTumour lysis syndrome: 2 case reports
Reactions Weekly, 2010, 1297 (1) : 23 - 23
[7] Antineoplastics/prednisoneNail dystrophy: 2 case reports
Reactions Weekly, 2010, 1284 (1) : 10 - 10
[8] BortezomibTumour lysis syndrome: 7 case reports
Reactions Weekly, 2007, 1141 (1) : 9 - 9
[9] Methylprednisolone/prednisoloneTumour lysis syndrome in paediatric patients: 2 case reports
Reactions Weekly, 2001, 877 (1) : 10 - 10
[10] BortezomibTumour lysis syndrome and acute renal failure: 3 case reports
Reactions Weekly, 2010, 1283 (1) : 24 - 24

← 1 2 3 4 5 →